Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A de Man

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|May 21, 1998
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatmentH G Niesters, P Honkoop, E B Haagsma, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 11, 1987
[Antiviral combination therapy in chronic hepatitis B]R A de Man, S W Schalm, R A Heijtink, et al.
Journal of Clinical Epidemiology|May 30, 2001
A psychometric comparison of health-related quality of life measures in chronic liver diseaseG Unal, J B de Boer, G J Borsboom, et al.
Journal of Viral Hepatitis|February 1, 2003
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis BD Sprengers, H L A Janssen, J Kwekkeboom, et al.
The British Journal of Surgery|August 9, 2003
Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatomaC Verhoef, J W Kuiper, J Heisterkamp, et al.
Journal of Viral Hepatitis|December 21, 2005
Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workersA A van der Eijk, R A de Man, H G M Niesters, et al.
Journal of Viral Hepatitis|April 22, 2018
Younger age and language barriers are associated with nonadherence to clinical follow-up in hepatitis B treatmentH Chi, A Japhary, R A de Man, et al.
The Netherlands Journal of Medicine|December 31, 2020
Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination scheduleT E M S de Vries-Sluijs, E R Andrinopoulou, R A de Man, et al.
Journal of Viral Hepatitis|May 16, 2002
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?A B van Nunen, R A de Man, R A Heijtink, et al.
Journal of Medical Virology|July 27, 2001
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexesR A Heijtink, A B van Nunen, P van Bergen, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|May 21, 1998
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatmentH G Niesters, P Honkoop, E B Haagsma, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 11, 1987
[Antiviral combination therapy in chronic hepatitis B]R A de Man, S W Schalm, R A Heijtink, et al.
Journal of Clinical Epidemiology|May 30, 2001
A psychometric comparison of health-related quality of life measures in chronic liver diseaseG Unal, J B de Boer, G J Borsboom, et al.
Journal of Viral Hepatitis|February 1, 2003
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis BD Sprengers, H L A Janssen, J Kwekkeboom, et al.
The British Journal of Surgery|August 9, 2003
Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatomaC Verhoef, J W Kuiper, J Heisterkamp, et al.
Journal of Viral Hepatitis|December 21, 2005
Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workersA A van der Eijk, R A de Man, H G M Niesters, et al.
Journal of Viral Hepatitis|April 22, 2018
Younger age and language barriers are associated with nonadherence to clinical follow-up in hepatitis B treatmentH Chi, A Japhary, R A de Man, et al.
The Netherlands Journal of Medicine|December 31, 2020
Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination scheduleT E M S de Vries-Sluijs, E R Andrinopoulou, R A de Man, et al.
Journal of Viral Hepatitis|May 16, 2002
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?A B van Nunen, R A de Man, R A Heijtink, et al.
Journal of Medical Virology|July 27, 2001
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexesR A Heijtink, A B van Nunen, P van Bergen, et al.
Pageof 20